aileron
therapeutics
present
upcoming
wainwright
virtual
global
investment
conference
watertown
globe
newswire
aileron
therapeutics
nasdaq
alrn
today
announced
manuel
aivado
president
chief
executive
officer
give
corporate
presentation
upcoming
wainwright
virtual
global
investment
conference
including
update
company
efforts
advance
chemoprotection
patients
cancers
regardless
cancer
type
chemotherapeutic
drug
presentation
scheduled
september
pm
et
live
webcast
presentation
available
investors
media
section
aileron
website
https
replay
live
webcast
archived
aileron
website
days
following
event
aileron
therapeutics
aileron
focused
transforming
experience
chemotherapy
cancer
patients
enabling
fight
cancer
without
fear
burden
side
effects
advancing
dual
mdmx
inhibitor
activates
clinical
development
provide
single
medicine
protect
multiple
healthy
cell
types
throughout
body
chemotherapy
ensuring
chemotherapy
continues
destroy
cancer
cells
addition
potentially
reducing
eliminating
multiple
side
effects
may
also
improve
patients
quality
life
help
better
tolerate
chemotherapy
thereby
allowing
patients
complete
treatment
without
dose
reductions
delays
vision
provide
chemoprotection
patients
cancers
represent
approximately
cancer
patients
regardless
cancer
type
chemotherapeutic
drug
visit
us
learn
investor
contacts
aileron
therapeutics
richard
wanstall
svp
chief
financial
officer
rwanstall
hans
vitzthum
lifesci
advisors
llc
hans
